We’re partnering with a small number of oncology teams to test Causomic on real Phase II programs.
Bring your compound and relevant clinical data.
Simulate your trial across thousands of virtual patients.
Explore different trial designs and identify the most promising approach.
Start with the compound, its mechanism of action, preclinical data, Phase I PK/PD, and indication. We build a model that matches the observed data, then simulate the compound across virtual patients.
Illustrative calibration on simulated data.
Simulate each protocol across thousands of virtual patients, varying eligibility criteria, biomarkers and patient characteristics to understand how each design performs across realistic populations.
Illustrative NSCLC cohort. These are simulation outputs, not results from a clinical trial.
Explore and compare thousands of possible Phase II designs across the same virtual population, before enrolling a single patient.
We’re partnering with a small number of teams to test Causomic on real Phase II programs and shape what comes next.
Talk to us